Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher S. Baliga
Observed names:
C BALIGA,
C.S. Baliga,
Christopher Baliga,
Christopher S Baliga
Institution:
Virginia Mason Medical Center
Observed institutions:
Virginia Mason Medical Center,
Baylor College of Medicine,
University Hospitals of Cleveland,
Case Western Reserve University
ORCID:
0000-0001-7832-4011
Observed ORCID:
0000-0001-7832-4011
OpenAlex ID:
A5044739636
Endoscopic Retrograde Cholangiopancreatography–Associated AmpC Escherichia coli Outbreak
2015
·
Kristen A. Wendorf
, Meagan Kay
, et al.
·
Infection Control and Hospital Epidemiology
·
199
PDF
A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli
2015
·
Andrew S. Ross
, Christopher Baliga
, et al.
·
Gastrointestinal Endoscopy
·
166
Diagnostic stewardship to improve patient outcomes and healthcare-associated infection (HAI) metrics
2024
·
Harjot K. Singh
, Kimberly C. Claeys
, et al.
·
Infection Control and Hospital Epidemiology
·
27
PDF
SHEA/APIC/IDSA/PIDS multisociety position paper: Raising the bar: necessary resources and structure for effective healthcare facility infection prevention and control programs
2025
·
Thomas R. Talbot
, Christopher Baliga
, et al.
·
Infection Control and Hospital Epidemiology
·
18
PDF
Policy statement from the Society for Healthcare Epidemiology of America (SHEA): Only medical contraindications should be accepted as a reason for not receiving all routine immunizations as recommended by the Centers for Disease Control and Prevention
2020
·
David J. Weber
, Thomas R. Talbot
, et al.
·
Infection Control and Hospital Epidemiology
·
18
PDF
Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities
2023
·
Eric J. Chow
, John B. Lynch
, et al.
·
Annals of Internal Medicine
·
5
PDF
Vaccination of Mice with Replication-Defective Human Immunodeficiency Virus Induces Cellular and Humoral Immunity and Protects against Vaccinia Virus-gag Challenge
2006
·
Christopher S. Baliga
, Marc van Maanen
, et al.
·
Molecular Therapy
·
5
PDF
HIV infection and acquired immunodeficiency syndrome
2008
·
Christopher S. Baliga
, Mary E. Paul
, et al.
·
Elsevier eBooks
·
3
Community respiratory viral metrics to inform masking in healthcare settings: A regional consensus approach
2024
·
Eric J. Chow
, Lawrence Lee
, et al.
·
Infection Control and Hospital Epidemiology
·
2
PDF
Tu1015 Culture and Quarantine Following High Level Disinfection of Duodenoscopes: Results of Ongoing Surveillance
2016
·
Andrew S. Ross
, Deborah Tombs
, et al.
·
Gastrointestinal Endoscopy
·
2
LB-6Endoscope-Associated Multidrug-Resistant Escherichia coli Outbreak — King County, Washington, 2012–2014
2014
·
Kristen Wendorf
, Meagan Kay
, et al.
·
Open Forum Infectious Diseases
·
2
PDF
The role of phenotyping and replication capacity in anti-HIV therapeutics.
2004
·
Christopher S Baliga
, Richard E Sutton
·
PubMed
·
2
Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities
2024
·
Eric J. Chow
, John B. Lynch
, et al.
·
Annals of Internal Medicine
·
1
SHEA/APIC/IDSA/PIDS multisociety position paper: Raising the bar: necessary resources and structure for effective healthcare facility infection prevention and control programs – CORRIGENDUM
2025
·
Thomas R. Talbot
, Christopher Baliga
, et al.
·
Infection Control and Hospital Epidemiology
PDF
Guiding Principles and Practices for Healthcare Outbreak Notification and Disclosures: CORHA Policy Workgroup Framework
2020
·
Maureen Tierney
, Moon Kim
, et al.
·
Infection Control and Hospital Epidemiology
PDF
Editorial Commentary
2015
·
Christopher S. Baliga
·
Urology Practice
559 Recognition and Resolution of Duodenoscope Associated Multi-Drug Resistant Bacterial Transmission
2015
·
Christopher Baliga
, Andrew S. Ross
, et al.
·
Gastrointestinal Endoscopy
The Spread of Multi-Drug Resistant Bacteria Following ERCP: Time to Redesign the Duodenoscope or Enhance Reprocessing?
2014
·
Christopher Baliga
, Andrew Ross
, et al.
·
The American Journal of Gastroenterology
VIH/sida
2007
·
Christopher S. Baliga
, William T. Shearer
·
Elsevier eBooks
Oral antigen delivery of varying doses of soluble or particulate antigens in the presence of adjuvant selectively induces Th1 or Th2 responses in systemic and mucosal compartments*1
2004
·
C BALIGA
·
Journal of Allergy and Clinical Immunology
Dose effect of mucosal adjuvant LT(R192G) on the induction of Th1 and Th2 immunity
2004
·
D.Q. Tran
, C.S. Baliga
, et al.
·
Journal of Allergy and Clinical Immunology
Show more works
View as search
Works count:
22
Citation count:
477
H-index:
5
I10-index:
5
Year
Topic
Type